Cargando…
Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Background: Currently, reported COVID-19 deaths are inadequate to assess the impact of the pandemic on global excess mortality. All-cause excess mortality is a WHO-recommended index for assessing the death burden of COVID-19. However, the global excess mortality assessed by this index remains unclea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607451/ https://www.ncbi.nlm.nih.gov/pubmed/36298567 http://dx.doi.org/10.3390/vaccines10101702 |
_version_ | 1784818547425280000 |
---|---|
author | Shang, Weijing Wang, Yaping Yuan, Jie Guo, Zirui Liu, Jue Liu, Min |
author_facet | Shang, Weijing Wang, Yaping Yuan, Jie Guo, Zirui Liu, Jue Liu, Min |
author_sort | Shang, Weijing |
collection | PubMed |
description | Background: Currently, reported COVID-19 deaths are inadequate to assess the impact of the pandemic on global excess mortality. All-cause excess mortality is a WHO-recommended index for assessing the death burden of COVID-19. However, the global excess mortality assessed by this index remains unclear. We aimed to assess the global excess mortality during the COVID-19 pandemic. Methods: We searched PubMed, EMBASE, and Web of Science for studies published in English between 1 January 2020, and 21 May 2022. Cross-sectional and cohort studies that reported data about excess mortality during the pandemic were included. Two researchers independently searched the published studies, extracted data, and assessed quality. The Mantel–Haenszel random-effects method was adopted to estimate pooled risk difference (RD) and their 95% confidence intervals (CIs). Results: A total of 79 countries from twenty studies were included. During the COVID-19 pandemic, of 2,228,109,318 individuals, 17,974,051 all-cause deaths were reported, and 15,498,145 deaths were expected. The pooled global excess mortality was 104.84 (95% CI 85.56–124.13) per 100,000. South America had the highest pooled excess mortality [134.02 (95% CI: 68.24–199.80) per 100,000], while Oceania had the lowest [−32.15 (95% CI: −60.53–−3.77) per 100,000]. Developing countries had higher excess mortality [135.80 (95% CI: 107.83–163.76) per 100,000] than developed countries [68.08 (95% CI: 42.61–93.55) per 100,000]. Lower middle-income countries [133.45 (95% CI: 75.10–191.81) per 100,000] and upper-middle-income countries [149.88 (110.35–189.38) per 100,000] had higher excess mortality than high-income countries [75.54 (95% CI: 53.44–97.64) per 100,000]. Males had higher excess mortality [130.10 (95% CI: 94.15–166.05) per 100,000] than females [102.16 (95% CI: 85.76–118.56) per 100,000]. The population aged ≥ 60 years had the highest excess mortality [781.74 (95% CI: 626.24–937.24) per 100,000]. Conclusions: The pooled global excess mortality was 104.84 deaths per 100,000, and the number of reported all-cause deaths was higher than expected deaths during the global COVID-19 pandemic. In South America, developing and middle-income countries, male populations, and individuals aged ≥ 60 years had a heavier excess mortality burden. |
format | Online Article Text |
id | pubmed-9607451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96074512022-10-28 Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis Shang, Weijing Wang, Yaping Yuan, Jie Guo, Zirui Liu, Jue Liu, Min Vaccines (Basel) Systematic Review Background: Currently, reported COVID-19 deaths are inadequate to assess the impact of the pandemic on global excess mortality. All-cause excess mortality is a WHO-recommended index for assessing the death burden of COVID-19. However, the global excess mortality assessed by this index remains unclear. We aimed to assess the global excess mortality during the COVID-19 pandemic. Methods: We searched PubMed, EMBASE, and Web of Science for studies published in English between 1 January 2020, and 21 May 2022. Cross-sectional and cohort studies that reported data about excess mortality during the pandemic were included. Two researchers independently searched the published studies, extracted data, and assessed quality. The Mantel–Haenszel random-effects method was adopted to estimate pooled risk difference (RD) and their 95% confidence intervals (CIs). Results: A total of 79 countries from twenty studies were included. During the COVID-19 pandemic, of 2,228,109,318 individuals, 17,974,051 all-cause deaths were reported, and 15,498,145 deaths were expected. The pooled global excess mortality was 104.84 (95% CI 85.56–124.13) per 100,000. South America had the highest pooled excess mortality [134.02 (95% CI: 68.24–199.80) per 100,000], while Oceania had the lowest [−32.15 (95% CI: −60.53–−3.77) per 100,000]. Developing countries had higher excess mortality [135.80 (95% CI: 107.83–163.76) per 100,000] than developed countries [68.08 (95% CI: 42.61–93.55) per 100,000]. Lower middle-income countries [133.45 (95% CI: 75.10–191.81) per 100,000] and upper-middle-income countries [149.88 (110.35–189.38) per 100,000] had higher excess mortality than high-income countries [75.54 (95% CI: 53.44–97.64) per 100,000]. Males had higher excess mortality [130.10 (95% CI: 94.15–166.05) per 100,000] than females [102.16 (95% CI: 85.76–118.56) per 100,000]. The population aged ≥ 60 years had the highest excess mortality [781.74 (95% CI: 626.24–937.24) per 100,000]. Conclusions: The pooled global excess mortality was 104.84 deaths per 100,000, and the number of reported all-cause deaths was higher than expected deaths during the global COVID-19 pandemic. In South America, developing and middle-income countries, male populations, and individuals aged ≥ 60 years had a heavier excess mortality burden. MDPI 2022-10-12 /pmc/articles/PMC9607451/ /pubmed/36298567 http://dx.doi.org/10.3390/vaccines10101702 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Shang, Weijing Wang, Yaping Yuan, Jie Guo, Zirui Liu, Jue Liu, Min Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title | Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title_full | Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title_fullStr | Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title_short | Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
title_sort | global excess mortality during covid-19 pandemic: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607451/ https://www.ncbi.nlm.nih.gov/pubmed/36298567 http://dx.doi.org/10.3390/vaccines10101702 |
work_keys_str_mv | AT shangweijing globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis AT wangyaping globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis AT yuanjie globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis AT guozirui globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis AT liujue globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis AT liumin globalexcessmortalityduringcovid19pandemicasystematicreviewandmetaanalysis |